In the first full review of cancer drugs in 15 years, WHO has added 16 new drugs to its essential medicines list, but the challenge is how low- and middle-income nations will pay for them.

The National Cancer Institute, the federal government’s main agency for cancer research and training, told CNN that at least 174 of its 608 trials may be affected by the shortages.However, that ...

The Food and Drug Administration is evaluating proposals for new indications for at least 17 oncology medicines, according to Friends of Cancer Research, an advocacy group that aims to get patients ...

The World Health Organization updated its guidelines for essential medicines Wednesday to include drugs to treat multiple sclerosis, heart conditions, cancer and more. But obesity medications were ...

Cancer drug shortage is forcing doctors to decide which patients get treatment . At least 11 cancer drugs are currently in short supply, FDA data shows. By Mary Kekatos. June 2, 2023, 5:06 AM.

Globally, spending on cancer drugs reached nearly $200 billion in 2020, according to the IQVIA Institute for Human Data Science. It is expected to reach $375 billion by 2027.

NEW ORLEANS — New immunotherapy drugs are showing significant and extended effectiveness against a broadening range of cancers, including rare and intractable tumors often caused by viruses ...

A cancer drug wish list. Shiva Malek, head of oncology at Novartis Institutes for Biomedical Research, discusses her drug development ambitions — including drugging transcription factors, ...